Sign in
NCEL Stock Price, Chart, Stats & News
NewcelX Ltd.
Save
NewcelX Ltd. (NCEL) does not currently pay a dividend.
1.66M
Market cap
–
Current P/E
–
Forward P/E
NCEL chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -49.93% |
ROE | -100.99% |
D/E | – |
Interest coverage ratio | -64.74x |
NCEL valuation
P/E | – |
P/S | – |
P/B | 0.31x |
P/CF | -0.18x |
P/FCF | -0.21x |
P/OCF | -0.18x |
PEG | 0.01x |
EV multiple | -1.07x |
About
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions.
Similar securities
Based on sector and market capitalization
Report issue